Summary & Overview

HCPCS J3490: Unclassified Drugs

HCPCS Level II code J3490 denotes unclassified drugs and is applied when a specific HCPCS drug code is not available. Nationally, J3490 serves as a catch‑all billing pathway for novel, off‑label, or otherwise unlisted medications administered in outpatient settings, making it consequential for reimbursement workflows, prior authorization processes, and claims adjudication. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find a concise explanation of what J3490 represents, typical clinical and billing contexts where it appears, and comparisons to related unclassified or compounded drug codes used in outpatient claims. The publication outlines common payer considerations and claims handling practices, highlights clinical scenarios that commonly trigger use of J3490, and summarizes coding relationships relevant to pharmacy and outpatient providers. Content addresses coding scope, typical sites of service, and how J3490 fits within broader drug billing workflows without providing clinical or legal advice. Data not available in the input is explicitly noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnited HealthcareMedicareJ3490HCPCS Level IIunclassified drugsdrug administrationoutpatient billingpharmacy codingclaims adjudicationprior authorization

Billing Code Overview

HCPCS Level II code J3490 is designated for unclassified drugs. This code is used to report single drug administrations or drug supplies when no specific HCPCS Level II code exists for the medication provided.

Service type: Drug administration / pharmacy-dispensed drug supply
Typical site of service: Hospital outpatient departments, physician offices, ambulatory infusion centers, and other outpatient settings where medications without an assigned HCPCS Level II code are administered or supplied.

Clinical & Coding Specifications

Clinical Context

A 68-year-old patient with multiple chronic conditions presents to the outpatient infusion clinic for receipt of a physician-administered medication that does not have a specific HCPCS level II code. The medication is billed using J3490 (unclassified drugs). The patient is established on long-term therapy documented with Z79.899 and attends periodic visits for therapeutic drug level monitoring (Z51.81). During a recent dosing visit the patient experienced new symptoms consistent with a drug reaction; the provider documents an adverse effect encounter using T50.905A. The clinical workflow includes: medication order entry by the prescribing family medicine or internal medicine physician, pharmacist verification and preparation, nursing administration in the clinic or physician office, documentation of lot number and dose, monitoring for immediate adverse effects, and scheduling follow-up for therapeutic drug monitoring or dose adjustment. Billing captures the unclassified drug using J3490, appropriate service modifiers to reflect site or circumstance, and the relevant diagnosis codes for the visit and ongoing therapy.

Coding Specifications

Modifier	Description	When to Use

Taxonomy Code	Specialty	Notes
`3336C0003X`	Pharmacist	Medication verification, preparation, compounding oversight, documentation of lot numbers.
`207Q00000X`	Family Medicine Physician	Prescribing and overall management of chronic therapy and adverse effect evaluation.
`207R00000X`	Internal Medicine Physician	Prescribing, monitoring, and management of complex adult chronic drug therapy.

ICD-10 Code	Description	Clinical Relevance
`Z79.899`	Other long term (current) drug therapy	Indicates ongoing chronic medication therapy for which an unclassified drug may be used or continued.
`T50.905A`	Adverse effect of unspecified drugs, initial encounter	Documents an acute adverse reaction prompting evaluation at the time of administration or follow-up.
`Z51.81`	Encounter for therapeutic drug level monitoring	Justifies laboratory monitoring related to dosing of medications billed with `J3490`.

OpenPayer